Reinhart Partners Inc. lowered its position in HealthSouth Corporation (NYSE:HLS) by 32.8% during the second quarter, Holdings Channel reports. The institutional investor owned 512,685 shares of the company’s stock after selling 249,707 shares during the period. HealthSouth Corporation comprises 2.5% of Reinhart Partners Inc.’s investment portfolio, making the stock its 12th largest position. Reinhart Partners Inc.’s holdings in HealthSouth Corporation were worth $24,814,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in the company. American International Group Inc. raised its stake in shares of HealthSouth Corporation by 3.4% in the first quarter. American International Group Inc. now owns 229,244 shares of the company’s stock worth $9,814,000 after buying an additional 7,579 shares in the last quarter. Sawgrass Asset Management LLC bought a new position in HealthSouth Corporation during the first quarter valued at $324,000. State of Alaska Department of Revenue bought a new position in HealthSouth Corporation during the first quarter valued at $235,000. Wedge Capital Management L L P NC raised its position in HealthSouth Corporation by 6.8% in the first quarter. Wedge Capital Management L L P NC now owns 453,792 shares of the company’s stock valued at $19,427,000 after buying an additional 28,989 shares during the period. Finally, Investec Asset Management LTD raised its position in HealthSouth Corporation by 4.6% in the first quarter. Investec Asset Management LTD now owns 226,365 shares of the company’s stock valued at $9,691,000 after buying an additional 10,000 shares during the period. 96.98% of the stock is currently owned by institutional investors.
HealthSouth Corporation (HLS) traded up 0.076% during mid-day trading on Monday, hitting $45.895. The stock had a trading volume of 352,045 shares. The company has a market cap of $4.11 billion, a price-to-earnings ratio of 17.138 and a beta of 0.63. The firm’s 50-day moving average is $46.98 and its 200 day moving average is $43.46. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71.
HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings data on Thursday, April 27th. The company reported $0.70 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.05. The company had revenue of $974.80 million during the quarter, compared to analyst estimates of $960.05 million. HealthSouth Corporation had a return on equity of 28.73% and a net margin of 6.80%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company earned $0.61 earnings per share. Equities analysts anticipate that HealthSouth Corporation will post $2.70 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 17th. Investors of record on Monday, July 3rd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Thursday, June 29th. HealthSouth Corporation’s dividend payout ratio is 35.96%.
Several brokerages have recently commented on HLS. Zacks Investment Research downgraded HealthSouth Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, April 25th. Barclays PLC restated an “underweight” rating and issued a $46.00 price target (up from $44.00) on shares of HealthSouth Corporation in a research note on Monday, May 1st. ValuEngine downgraded HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. BidaskClub upgraded HealthSouth Corporation from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Finally, KeyCorp initiated coverage on HealthSouth Corporation in a research note on Thursday, June 15th. They issued a “sector weight” rating for the company. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $49.71.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.